DaVita (DVA)
192.17
0.00 (0.00%)
Upcoming Events
Latest Headlines
Form 4 DAVITA INC. For: May 26 Filed by: YALE PHYLLIS R
May 28, 2026 5:10 PM - SEC Filing
DaVita Sets Bold 2030 Community Care Commitments After Exceeding Prior Five-Year ESG Goals
May 19, 2026 12:10 PM - StreetInsider
Form 4 DAVITA INC. For: May 15 Filed by: Pullin Dennis W
May 18, 2026 4:18 PM - SEC Filing
Form 4 DAVITA INC. For: May 15 Filed by: Moore Gregory J.
May 18, 2026 4:17 PM - SEC Filing
Form 4 DAVITA INC. For: May 15 Filed by: DESOER BARBARA J
May 18, 2026 4:17 PM - SEC Filing
Form 4 DAVITA INC. For: May 15 Filed by: Arway Pamela M
May 18, 2026 4:17 PM - SEC Filing
Form 4 DAVITA INC. For: May 15 Filed by: YALE PHYLLIS R
May 18, 2026 4:17 PM - SEC Filing
Form 4 DAVITA INC. For: May 15 Filed by: Schoppert Wendy Lee
May 18, 2026 4:17 PM - SEC Filing
Form 4 DAVITA INC. For: May 15 Filed by: Hollar Jason M.
May 18, 2026 4:17 PM - SEC Filing
Form 4 DAVITA INC. For: May 15 Filed by: Schechter Adam H
May 18, 2026 4:17 PM - SEC Filing
Form 4 DAVITA INC. For: May 14 Filed by: HEARTY JAMES O
May 18, 2026 4:13 PM - SEC Filing
DaVita Sets Bold 2030 Community Care Commitments After Exceeding Prior Five-Year ESG Goals
May 18, 2026 3:00 PM - PR NewsWire
Form 144 DAVITA INC. Filed by: HEARTY JAMES O
May 15, 2026 3:13 PM - SEC Filing
Form 4 DAVITA INC. For: May 11 Filed by: Maughan David Paul
May 13, 2026 4:10 PM - SEC Filing
Form 144 DAVITA INC. Filed by: Maughan David Paul
May 11, 2026 5:40 PM - SEC Filing
Form 4 DAVITA INC. For: May 07 Filed by: ACKERMAN JOEL
May 11, 2026 4:07 PM - SEC Filing
DaVita (DVA) PT Raised to $201 at TD Cowen
May 11, 2026 7:56 AM - StreetInsider
Form 4 DAVITA INC. For: May 06 Filed by: HEARTY JAMES O
May 8, 2026 4:05 PM - SEC Filing
DaVita (DVA) PT Raised to $205 at Truist Securities
May 8, 2026 7:18 AM - StreetInsider
DaVita (DVA) PT Raised to $194 at Barclays
May 8, 2026 4:05 AM - StreetInsider
Form 144 DAVITA INC. Filed by: ACKERMAN JOEL
May 7, 2026 4:43 PM - SEC Filing
DaVita (DVA) PT Raised to $235 at UBS
May 7, 2026 9:39 AM - StreetInsider
DaVita Inc. to Participate in the BofA Securities 2026 Health Care Conference
May 6, 2026 6:01 PM - PR NewsWire
Form 144 DAVITA INC. Filed by: HEARTY JAMES O
May 6, 2026 4:04 PM - SEC Filing
DaVita (DVA) PT Raised to $145 at BofA Securities
May 6, 2026 4:26 AM - StreetInsider
Deutsche Bank Upgrades DaVita (DVA) to Buy
May 6, 2026 3:38 AM - StreetInsider
Form 4 DAVITA INC. For: May 01 Filed by: BUFFETT WARREN E
May 5, 2026 6:53 PM - SEC Filing
Form 10-Q DAVITA INC. For: Mar 31
May 5, 2026 5:03 PM - SEC Filing
DaVita (DVA) Tops Q1 EPS by 55c; raises guidance
May 5, 2026 4:14 PM - StreetInsider
Form 8-K DAVITA INC. For: May 05
May 5, 2026 4:10 PM - SEC Filing
DaVita Inc. 1st Quarter 2026 Results
May 5, 2026 4:05 PM - PR NewsWire
Honeywell names 11-member board for aerospace spinoff
April 28, 2026 7:01 AM - StreetInsider
Honeywell Announces Board of Directors for Honeywell Aerospace
April 28, 2026 7:00 AM - PR NewsWire
Form ARS DAVITA INC. For: Dec 31
April 22, 2026 4:57 PM - SEC Filing
Form DEFA14A DAVITA INC.
April 22, 2026 4:48 PM - SEC Filing
Form DEF 14A DAVITA INC. For: Dec 31
April 22, 2026 4:32 PM - SEC Filing
DaVita Inc. Schedules 1st Quarter 2026 Investor Conference Call
April 20, 2026 2:06 PM - PR NewsWire
Form SCHEDULE 13G/A DAVITA INC. Filed by: VANGUARD GROUP INC
March 26, 2026 5:40 PM - SEC Filing
DaVita achieves 9% quality improvement in kidney care program
March 18, 2026 3:00 PM - StreetInsider
DaVita achieves 9% quality improvement in kidney care program
March 18, 2026 3:00 PM - StreetInsider
DaVita Highlights Continued Progress in Value-Based Kidney Care as CKCC Results Show Year-Over-Year Improvement
March 18, 2026 3:00 PM - PR NewsWire
Form 4 DAVITA INC. For: Mar 15 Filed by: Arway Pamela M
March 17, 2026 4:11 PM - SEC Filing
Form 4 DAVITA INC. For: Mar 15 Filed by: DESOER BARBARA J
March 17, 2026 4:11 PM - SEC Filing
Form 4 DAVITA INC. For: Mar 15 Filed by: Rodriguez Javier
March 17, 2026 4:11 PM - SEC Filing
Form 4 DAVITA INC. For: Mar 15 Filed by: YALE PHYLLIS R
March 17, 2026 4:11 PM - SEC Filing
Form 4 DAVITA INC. For: Mar 15 Filed by: Pullin Dennis W
March 17, 2026 4:10 PM - SEC Filing
Form 4 DAVITA INC. For: Mar 15 Filed by: Maughan David Paul
March 17, 2026 4:10 PM - SEC Filing
Form 4 DAVITA INC. For: Mar 15 Filed by: BERRY CHRISTOPHER MICHAEL
March 17, 2026 4:10 PM - SEC Filing
Form 4 DAVITA INC. For: Mar 15 Filed by: Hollar Jason M.
March 17, 2026 4:10 PM - SEC Filing
Form 4 DAVITA INC. For: Mar 15 Filed by: ACKERMAN JOEL
March 17, 2026 4:10 PM - SEC Filing
Form 4 DAVITA INC. For: Mar 15 Filed by: Moore Gregory J.
March 17, 2026 4:10 PM - SEC Filing
Form 4 DAVITA INC. For: Mar 15 Filed by: Schechter Adam H
March 17, 2026 4:10 PM - SEC Filing
Form 4 DAVITA INC. For: Mar 15 Filed by: Waters Kathleen Alyce
March 17, 2026 4:10 PM - SEC Filing
Form 4 DAVITA INC. For: Mar 15 Filed by: HEARTY JAMES O
March 17, 2026 4:10 PM - SEC Filing
Form 4 DAVITA INC. For: Mar 15 Filed by: Schoppert Wendy Lee
March 17, 2026 4:10 PM - SEC Filing
Alebund licenses kidney drug AP306 to R1 Therapeutics outside China
March 17, 2026 8:01 AM - StreetInsider
Alebund Pharmaceuticals Announces Collaboration and License Agreement with R1 Therapeutics for AP306
March 17, 2026 8:00 AM - PR NewsWire
R1 Therapeutics launches with oversubscribed $77.5 million Series A financing to advance first-in-class treatment for hyperphosphatemia in patients with chronic kidney disease
March 17, 2026 7:00 AM - Globe NewsWire
Form 4 DAVITA INC. For: Mar 10 Filed by: ACKERMAN JOEL
March 12, 2026 4:06 PM - SEC Filing
Form 4 DAVITA INC. For: Mar 10 Filed by: HEARTY JAMES O
March 12, 2026 4:06 PM - SEC Filing
Form 4 DAVITA INC. For: Mar 10 Filed by: Waters Kathleen Alyce
March 12, 2026 4:06 PM - SEC Filing
Full Article List
